UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026248
Receipt number R000030146
Scientific Title Comprehensive study of cognitive function associated with psychopathological symptoms and brain function
Date of disclosure of the study information 2017/02/21
Last modified on 2024/02/27 13:50:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comprehensive study of cognitive function associated with psychopathological symptoms and brain function

Acronym

Comprehensive study of cognitive function associated with psychopathological symptoms and brain function

Scientific Title

Comprehensive study of cognitive function associated with psychopathological symptoms and brain function

Scientific Title:Acronym

Comprehensive study of cognitive function associated with psychopathological symptoms and brain function

Region

Japan


Condition

Condition

Healthy individuals

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to develop objective method to assess psychopathological symptoms and new method of treatment by comprehensive analysis of psychological data and brain imaging data.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Classification of psychopathological symptoms by cpmprehensive statistical analysis

Key secondary outcomes

Associtation among cognitive function, psychopathological symptoms, and MRI data


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy individuals who have the ability to provide informed consent.

Key exclusion criteria

Psychiatric disorders including drug dependence
Serious medical illness

Target sample size

401


Research contact person

Name of lead principal investigator

1st name Yamada
Middle name
Last name Makiko

Organization

National Institutes for Quantum Science and Technology
Quantum Life and Medical Science Directorate
Institute for Quantum Medical Science

Division name

Department of Functional Brain Imaging Research

Zip code

263-8555

Address

4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

043-206-3251

Email

yamada.makiko@qst.go.jp


Public contact

Name of contact person

1st name Kazuko
Middle name
Last name Suzuki

Organization

National Institutes for Quantum Science and Technology Institute for Quantum Medical Science

Division name

Assistance division of clinical research

Zip code

263-8555

Address

4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

043-206-3025

Homepage URL


Email

suzuki.kazuko@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Science and Technology
Quantum Life and Medical Science Directorate
Institute for Quantum Medical Science

Institute

Department

Personal name



Funding Source

Organization

National Institutes for Quantum Science and Technology
Quantum Life and Medical Science Directorate
Institute for Quantum Medical Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Certified Review Board

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba

Tel

043-206-4709

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 07 Month 29 Day

Date of IRB

2016 Year 07 Month 29 Day

Anticipated trial start date

2017 Year 02 Month 21 Day

Last follow-up date

2018 Year 07 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Comprehensive statistical analysis of psychological data and MRI data


Management information

Registered date

2017 Year 02 Month 21 Day

Last modified on

2024 Year 02 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030146


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name